Clinical trial
Efficacy and Safety of Salmon Calcitonin Nasal Spray in Improving Muscle…
NCT00239889 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00239889 |
|---|---|
| Title | Efficacy and Safety of Salmon Calcitonin Nasal Spray in Improving Muscle Strength and Reducing Pain After Forearm Fracture in Postmenopausal Women |
| Official title | Efficacy and Safety of Salmon Calcitonin Nasal Spray in Improving Muscle Strength and Reducing Pain After Forearm Fracture in Postmenopausal Women |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Forearm Fracture |
| Intervention type | Drug |
| Interventions | Salmon calcitonin |
| Enrollment | 300 |
| Start date | Mar 1, 2002 |
| First posted | Oct 17, 2005 |
| Last update posted | Nov 30, 2006 |
| Countries | Germany, Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: